Using population pharmacokinetics to determine gentamicin dosing during extended daily diafiltration in critically ill patients with acute kidney injury.
about
DALI: Defining Antibiotic Levels in Intensive care unit patients: a multi-centre point of prevalence study to determine whether contemporary antibiotic dosing for critically ill patients is therapeutic.ASAP ECMO: Antibiotic, Sedative and Analgesic Pharmacokinetics during Extracorporeal Membrane Oxygenation: a multi-centre study to optimise drug therapy during ECMO.Antibiotic dosing in critically ill patients with acute kidney injury.Rational use of aminoglycosides--review and recommendations by the Swedish Reference Group for Antibiotics (SRGA).Aminoglycosides in septic shock: an overview, with specific consideration given to their nephrotoxic risk.Antibiotic Dosing in Patients With Acute Kidney Injury: "Enough But Not Too Much".Prolonged intermittent renal replacement therapy in children.Dose Timing of Aminoglycosides in Hemodialysis Patients: A Pharmacology View.Therapeutic drug monitoring of anti-infective agents in critically ill patients.Population pharmacokinetic modelling, Monte Carlo simulation and semi-mechanistic pharmacodynamic modelling as tools to personalize gentamicin therapy.Gentamicin in hemodialyzed critical care patients: early dialysis after administration of a high dose should be considered.Population pharmacokinetics and dosing simulations of ceftazidime in critically ill patients receiving sustained low-efficiency dialysis.[Hot rods in the ICU : What is the antibiotic mileage of your renal replacement therapy?]Survey of pharmacists’ antibiotic dosing recommendations for sustained low-efficiency dialysis.
P2860
Q34329290-4AAFD746-C39B-4B25-A4D0-EC5CCBA73BBAQ34494688-AC08C393-0B8D-4367-AD5E-DAA3B6B0FF72Q37846092-1AA07253-B725-47FA-8CC9-92BC39EB5961Q38070006-40699CAC-6160-438D-A3D8-EE92758D4463Q38090988-832AD86B-7A4F-4DA9-A8A2-8F82DCBF15F4Q38261172-C1D55F7A-DE07-4114-8BE0-82CEA18DEE7AQ38672943-93055BB6-AB66-4F32-9D70-8CB896474312Q38693212-3933E93E-BB56-448B-AE62-4AF64E91C56AQ38790740-73898674-B77C-4F94-80CD-510EADA5CF07Q39071799-C4910E99-860C-4121-A6D4-1B98F3AE11AAQ42952777-43A5C9B8-907C-4170-909B-C80FA4BB79EBQ47442689-6AD1FBF3-6FF1-42E2-B397-821ED4FB3F31Q50032998-6703F12C-D6AC-47C9-83ED-42CD7DE5E194Q53305981-DAD1BE62-BF5F-4CD1-A826-1E9972939B77
P2860
Using population pharmacokinetics to determine gentamicin dosing during extended daily diafiltration in critically ill patients with acute kidney injury.
description
2010 nî lūn-bûn
@nan
2010 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի հունիսին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
Using population pharmacokinet ...... ents with acute kidney injury.
@ast
Using population pharmacokinet ...... ents with acute kidney injury.
@en
Using population pharmacokinet ...... ents with acute kidney injury.
@nl
type
label
Using population pharmacokinet ...... ents with acute kidney injury.
@ast
Using population pharmacokinet ...... ents with acute kidney injury.
@en
Using population pharmacokinet ...... ents with acute kidney injury.
@nl
prefLabel
Using population pharmacokinet ...... ents with acute kidney injury.
@ast
Using population pharmacokinet ...... ents with acute kidney injury.
@en
Using population pharmacokinet ...... ents with acute kidney injury.
@nl
P2093
P2860
P356
P1476
Using population pharmacokinet ...... ents with acute kidney injury.
@en
P2093
Adam Visser
Carl M J Kirkpatrick
Jonathan Field
Mandy Tallot
Rosemary Whitbread
P2860
P304
P356
10.1128/AAC.00222-10
P407
P577
2010-06-14T00:00:00Z